Read More Pharma Industry News Longboard Pharmaceuticals shares see spike as FDA recognizes potential of bexicaserin in Dravet syndrome Shares of Longboard Pharmaceuticals, Inc. surged on Thursday after the United States Food and Drug Administration (FDA) granted… byPallavi MadhirajuSeptember 19, 2024